FDA Inspection
La Jolla IVFLa Jolla IVF – FDA Inspection, Sep 17, 2010
Record Details
This FDA Inspection record concerns La Jolla IVF, with an inspection on September 17, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- La Jolla IVF
- Inspection Date
- September 17, 2010
- Product Type
- Biologics
View Company Profile
ID · ab62f414-194d-4722-b267-b8f36be9c864
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 680725
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.47(b)Review and approval of procedures
- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.47(a)Procedures for all other requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of La Jolla IVF
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 23, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 7, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 13, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 22, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for La Jolla IVF
- FDA Inspection 1315918 - 2026-04-23
- FDA Inspection 1216984 - 2023-08-07
- FDA Inspection 1059998 - 2018-07-13
- FDA Inspection 911460 - 2015-01-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.